Condensed Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total		Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain/(Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022			48,941,254
Beginning balance at Dec. 31, 2022	$ 313,342		$ 5	$ 653,707	$ (1,958)	$ (338,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued in a public offering, net of offering expenses (in shares)			9,583,334
Common stock issued in a public offering, net of offering expenses	269,915		$ 1	269,914
Issuance of common stock under benefit plans (in shares)			454,314
Issuance of common stock under benefit plans	3,661			3,661
Stock-based compensation expense	11,923			11,923
Net unrealized (loss) gain on short-term investments	627				627
Net loss	(37,548)					(37,548)
Ending balance (in shares) at Mar. 31, 2023			58,978,902
Ending balance at Mar. 31, 2023	$ 561,920		$ 6	939,205	(1,331)	(375,960)
Beginning balance (in shares) at Dec. 31, 2023	59,921,002		59,921,002
Beginning balance at Dec. 31, 2023	$ 473,576	[1]	$ 6	972,973	345	(499,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under benefit plans (in shares)			397,540
Issuance of common stock under benefit plans	1,879			1,879
Stock-based compensation expense	9,666			9,666
Net unrealized (loss) gain on short-term investments	(834)				(834)
Net loss	$ (46,955)					(46,955)
Ending balance (in shares) at Mar. 31, 2024	60,318,542		60,318,542
Ending balance at Mar. 31, 2024	$ 437,332		$ 6	$ 984,518	$ (489)	$ (546,703)

[1] The condensed balance sheet as of December 31, 2023 has been derived from the audited financial statements as of that date.